The Refinancing Reckoning: A Director’s Framework for Mid-Market Debt Decisions

Across the U.S. mid-market, a concentration of loan maturities arrives in 2027 and 2028. For many private companies, the practical question is not whether refinancing will occur, but whether the board will shape the terms or merely ratify them. Refinancing has long been treated as a treasury task—a matter of spreads, fees, and signatures. That framing is no longer adequate. A refinancing decision allocates risk across lenders, employees, and owners. It can preserve or impair enterprise value. It belongs on the board agenda well before the maturity date appears in the loan agreement.

Refinancing Is a Governance Event

The board’s role is not to negotiate the coupon. It is to establish the constraints within which management negotiates. Directors should define the acceptable range of leverage, the minimum liquidity cushion, the covenant package the company can live with in a downside case, and the conditions under which the company would rather pay down debt than extend it.

This distinction matters because refinancing decisions are often made under time pressure. When the lender’s term sheet arrives six weeks before maturity, the board’s leverage is limited. When the board has already set thresholds and tested scenarios, management enters the conversation with a mandate rather than a request.

Start With the Covenant Ledger

Covenant headroom is not a single ratio. It is a schedule of tests, definitions, and measurement dates. Directors should request a covenant ledger that shows, for each facility, the financial covenants, the testing frequency, the trailing-twelve-month EBITDA definition, the permitted add-backs, the fixed-charge coverage ratio, the leverage ratio, and any springing covenants tied to liquidity.

The ledger should also identify which covenants are maintenance tests and which are incurrence tests. Maintenance covenants can be triggered by a weak quarter. Incurrence covenants are triggered by an action—an acquisition, a dividend, or additional debt. Boards that conflate the two often misjudge the timing of risk.

A second request is equally important: a reconciliation of reported EBITDA to covenant EBITDA. The difference between the two can be material, particularly for companies that have grown through acquisitions or carry significant non-recurring charges. Directors should ask management to walk through the add-backs line by line and to identify any add-back that a new lender might disallow.

Three Stress Tests Before the Lender’s Call

Boards do not need to build the model, but they should require management to run three stress tests and present the results in plain terms.

First, an earnings compression test. Reduce EBITDA by 10 to 15 percent and observe the resulting leverage and coverage ratios. Second, a rate reset test. Assume the base rate rises by 150 to 200 basis points and calculate the impact on cash interest and covenant compliance. Third, a liquidity shock test. Model a delayed receivables cycle or an unplanned capital expenditure and determine how quickly the company approaches any springing covenant.

If any of these tests produces a covenant breach with less than a 15 to 20 percent cushion, the board should treat refinancing as a near-term governance matter rather than a future treasury project. The purpose of the tests is not to predict the future. It is to establish how much room the company has before the future becomes urgent.

The Extend-or-Amortize Decision

The choice between extending debt and paying it down is often framed as a cost-of-capital question. It is also a risk question. Extension preserves liquidity and flexibility, but it may require accepting tighter covenants, additional collateral, or a higher all-in cost. Paying down debt reduces leverage and interest expense, but it consumes cash that may be needed for operations or opportunistic investment.

The board should set decision rules in advance. For example: if the downside case produces a covenant cushion below an agreed threshold, the company will pursue extension with revised terms. If the company holds excess cash above a defined operating reserve, it will apply a portion to debt reduction. If neither condition applies, management will present a restructuring or recapitalization plan before the next board cycle.

These rules are not meant to replace judgment. They are meant to prevent judgment from being compressed into a single meeting under deadline pressure.

Comparing Lenders on More Than Rate

Regional banks, private credit funds, and business development companies now compete for mid-market borrowers, but they do not offer interchangeable products. Directors should ask for a side-by-side comparison that includes the all-in cost, the covenant package, collateral requirements, prepayment penalties, reporting obligations, and the lender’s likely behavior in a workout scenario.

A lower coupon can be misleading if the covenant package is tight or the lender has limited appetite for future amendments. A higher coupon may be justified if the lender offers certainty of execution, a longer tenor, or a more flexible covenant structure. The board’s question is not which lender is cheapest. It is which lender’s terms best fit the company’s operating reality and downside risk.

A Four-Quarter Board Calendar

Refinancing should be sequenced across four quarters, not four weeks. In the first quarter, the board should inventory maturities, review the covenant ledger, and approve the stress-test scenarios. In the second quarter, management should begin informal conversations with existing lenders and evaluate alternative sources. In the third quarter, the board should review term sheets and approve a preferred path. In the fourth quarter, the company should execute and document the decision.

This calendar is deliberately conservative. It assumes that lender appetite can change, that documentation takes longer than expected, and that the board may need more than one meeting to resolve disagreements. The cost of starting early is modest. The cost of starting late is often measured in lost negotiating leverage.

Questions for the Record

Every board should be able to answer the following questions in its minutes: What are the maturity dates and covenant tests for each facility? What is the covenant EBITDA reconciliation? What happens to compliance under a 15 percent EBITDA decline? What is the all-in cost of the current facility compared with available alternatives? What conditions would cause the board to prefer paydown over extension? Who is responsible for lender outreach, and by when?

The answers need not be perfect. They need to be documented. A board that records its reasoning today will be better positioned to defend its decisions tomorrow—and to act before the calendar sets the terms.